These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. A survey on the efficacy and tolerability of micronized fenofibrate in patients with dyslipidemia. Zhu J; Ye P Chin Med J (Engl); 2003 Jun; 116(6):840-3. PubMed ID: 12877791 [TBL] [Abstract][Full Text] [Related]
26. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. Jones PH; Davidson MH Am J Cardiol; 2005 Jan; 95(1):120-2. PubMed ID: 15619408 [TBL] [Abstract][Full Text] [Related]
27. After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: implications for fenofibrate. Sacks FM Am J Cardiol; 2008 Dec; 102(12A):34L-40L. PubMed ID: 19084088 [TBL] [Abstract][Full Text] [Related]
28. [Fenofibrate 250 SR Pharmavit in patients with mixed hyperlipoproteinemia. Results of a study of 189 patients from 13 centers in the Czech Republic]. Ceska R; Stulc T Cas Lek Cesk; 2000 Jun; 139(12):369-73. PubMed ID: 10953407 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study. Davidson MH; Bays H; Rhyne J; Stein E; Rotenberg K; Doyle R Clin Ther; 2005 Jun; 27(6):715-27. PubMed ID: 16117978 [TBL] [Abstract][Full Text] [Related]
31. Fenofibrate-induced photosensitivity - a case series and literature review. Tsai KC; Yang JH; Hung SJ Photodermatol Photoimmunol Photomed; 2017 Jul; 33(4):213-219. PubMed ID: 28317179 [No Abstract] [Full Text] [Related]
32. Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia. McKenney JM; Farnier M; Lo KW; Bays HE; Perevozkaya I; Carlson G; Davies MJ; Mitchel YB; Gumbiner B J Am Coll Cardiol; 2006 Apr; 47(8):1584-7. PubMed ID: 16630994 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia. Farnier M; Freeman MW; Macdonell G; Perevozskaya I; Davies MJ; Mitchel YB; Gumbiner B; Eur Heart J; 2005 May; 26(9):897-905. PubMed ID: 15781429 [TBL] [Abstract][Full Text] [Related]
34. Fenofibric Acid (trilipix). Med Lett Drugs Ther; 2009 May; 51(1311):33-4. PubMed ID: 19417718 [No Abstract] [Full Text] [Related]
35. Targeting vascular risk in patients with metabolic syndrome but without diabetes. Athyros VG; Mikhailidis DP; Papageorgiou AA; Didangelos TP; Peletidou A; Kleta D; Karagiannis A; Kakafika AI; Tziomalos K; Elisaf M Metabolism; 2005 Aug; 54(8):1065-74. PubMed ID: 16092057 [TBL] [Abstract][Full Text] [Related]
36. [Retentive photosensitivity induced by chlorproethazine]. Jeanmougin M; Sigal-Nahum M; Manciet JR; Petit A; Flageul B; Dubertret L Ann Dermatol Venereol; 1993; 120(11):840-3. PubMed ID: 8210139 [No Abstract] [Full Text] [Related]